Owners, management and financials
CVR: 38445928
Secondary names: OV-SPV2 ApS, Oncology Venture SPV2 ApS
Previous names: OV-SPV2 ApS
DKK 0
Gross profit
Net result: DKK 0
Allarity Acquisition Subsidiary, Inc. (100%)
CVR · view owners
Steen Meier Knudsen, Jeffrey Stuart Ervin
CVR · view management
Active
Founded 13 February 2017
CVR · view overview
0 employees
Annual report 2025 · average
Director role ended: Alexander Epshinsky
CVR · 04/07/2025
View the full event history
Allarity Therapeutics Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named OV-SPV2 ApS. The management consists of Steen Meier Knudsen and Jeffrey Stuart Ervin. The company is owned by Allarity Acquisition Subsidiary, Inc.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 174,000 the year before. Equity in the 2025 report amounted to DKK -2,476,000.
Selskabets formål er at undersøge om et stof fra Big Pharma kan anvendes sammen med DRPTM.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 0 | 0 | 4 t. | -2.5 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | 33 t. | 174 t. | 4 t. | -2.5 mio. | - | |
| 202301/01/2023 – 31/12/2023 | - | -1.2 mio. | 6.6 mio. | -2.6 mio. | - | |
| 202201/01/2022 – 31/12/2022 | 0 | -1.5 mio. | 6.6 mio. | -1.4 mio. | - | |
| 202101/01/2021 – 31/12/2021 | -1 t. | 0 | 6.9 mio. | 23 t. | 0 | |
| 202001/01/2020 – 31/12/2020 | -2.2 mio. | -1.6 mio. | 12.6 mio. | 22 t. | - | |
| 201901/01/2019 – 31/12/2019 | -1.5 mio. | -1.2 mio. | 12.1 mio. | 1.7 mio. | - | |
| 201801/01/2018 – 31/12/2018 | -349 t. | -170 t. | 9.7 mio. | 2.9 mio. | - | |
| 201713/02/2017 – 31/12/2017 | -13 t. | 339 | 3.2 mio. | 50 t. | - |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Allarity Therapeutics Denmark ApS is 38445928.
Allarity Therapeutics Denmark ApS is owned by Allarity Acquisition Subsidiary, Inc..
The management of Allarity Therapeutics Denmark ApS consists of Steen Meier Knudsen and Jeffrey Stuart Ervin.
In 2025, Allarity Therapeutics Denmark ApS reported a gross profit of DKK 0.
Allarity Therapeutics Denmark ApS had an average of 0 employees in the 2025 financial year according to the annual report.
Allarity Therapeutics Denmark ApS was founded on 13 February 2017.
Claim this page to add your logo and social links. Free to get started.
Allarity Therapeutics Denmark ApS has published its annual report for 2025. Gross profit came to DKK 0, and the net result was DKK 0.
As of July 4, 2025, Jeffrey Stuart Ervin is registered as director of Allarity Therapeutics Denmark ApS.
As of July 4, 2025, Alexander Epshinsky has stepped down as director of Allarity Therapeutics Denmark ApS.
Allarity Therapeutics Denmark ApS has published its annual report for 2024. Gross profit came to DKK 33,000, and the net result was DKK 174,000.
As of September 12, 2024, Alexander Epshinsky is registered as director of Allarity Therapeutics Denmark ApS.
As of September 12, 2024, Joan Yvonne Brown has stepped down as director of Allarity Therapeutics Denmark ApS.
Allarity Therapeutics Denmark ApS has published its annual report for 2023. The net result was DKK -1,220,000.
As of December 12, 2023, Steen Meier Knudsen is registered as adm. dir. of Allarity Therapeutics Denmark ApS.
As of December 12, 2023, James G. Cullem has stepped down as adm. dir. of Allarity Therapeutics Denmark ApS.
As of December 11, 2023, Steen Meier Knudsen has stepped down as director of Allarity Therapeutics Denmark ApS.
Allarity Therapeutics Denmark ApS has published its annual report for 2022. Gross profit came to DKK 0, and the net result was DKK -1,453,000.
As of August 1, 2022, Steen Meier Knudsen is registered as director of Allarity Therapeutics Denmark ApS.
Allarity Therapeutics Denmark ApS has published its annual report for 2021. Gross profit came to DKK -1,000, and the net result was DKK 0.
As of July 25, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Allarity Therapeutics Denmark ApS.
As of July 25, 2022, Joan Yvonne Brown is registered as director of Allarity Therapeutics Denmark ApS.
As of June 29, 2022, James G. Cullem is registered as adm. dir. of Allarity Therapeutics Denmark ApS.
As of June 29, 2022, Stefano Roberto Carchedi has stepped down as adm. dir. of Allarity Therapeutics Denmark ApS.
As of June 28, 2022, James G. Cullem has stepped down as director of Allarity Therapeutics Denmark ApS.
As of June 27, 2022, Jens Erik Knudsen has stepped down as director of Allarity Therapeutics Denmark ApS.
As of February 1, 2022, James G. Cullem is registered as director of Allarity Therapeutics Denmark ApS.
As of December 23, 2021, Jens Erik Knudsen is registered as director of Allarity Therapeutics Denmark ApS.
As of December 23, 2021, Stefano Roberto Carchedi is registered as adm. dir. of Allarity Therapeutics Denmark ApS.
As of December 23, 2021, Thomas Henrik Jensen has stepped down as director of Allarity Therapeutics Denmark ApS.
On December 23, 2021, the company changed its name from OV-SPV2 ApS to Allarity Therapeutics Denmark ApS.
As of December 21, 2021, is registered as an owner of Allarity Therapeutics Denmark ApS with an ownership share of 100%.
Allarity Therapeutics Denmark ApS has published its annual report for 2020. Gross profit came to DKK -2,169,000, and the net result was DKK -1,645,000.
Allarity Therapeutics Denmark ApS has published its annual report for 2019. Gross profit came to DKK -1,512,000, and the net result was DKK -1,238,000.
Allarity Therapeutics Denmark ApS has published its annual report for 2018. Gross profit came to DKK -348,971, and the net result was DKK -169,894.
As of December 11, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Allarity Therapeutics Denmark ApS.
As of December 11, 2018, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Allarity Therapeutics Denmark ApS.
As of December 11, 2018, Thomas Henrik Jensen has left the board of directors of Allarity Therapeutics Denmark ApS.
As of December 11, 2018, Peter Buhl has left the board of directors of Allarity Therapeutics Denmark ApS.
As of December 11, 2018, Ulla Hald Buhl has left the board of directors of Allarity Therapeutics Denmark ApS.
Allarity Therapeutics Denmark ApS has published its interim report for the period February 13, 2017 – December 31, 2017.
As of February 13, 2017, EY Godkendt Revisionspartnerselskab has been appointed auditor of Allarity Therapeutics Denmark ApS.
As of February 13, 2017, Thomas Henrik Jensen has joined the board of directors of Allarity Therapeutics Denmark ApS.
As of February 13, 2017, Peter Buhl has joined the board of directors of Allarity Therapeutics Denmark ApS.
As of February 13, 2017, Ulla Hald Buhl has joined the board of directors of Allarity Therapeutics Denmark ApS.
As of February 13, 2017, Thomas Henrik Jensen is registered as director of Allarity Therapeutics Denmark ApS.
Allarity Therapeutics Denmark ApS was founded on February 13, 2017.
Companies in the same industry and area
CVR 34623562
CVR 29526346
CVR 37728403
CVR 40279865
CVR 63717916
